Cases & Deals

  • Home
  • Practices
  • Life sciences company resolves FCPA issues with DOJ and SEC

Share

Life sciences company resolves FCPA issues with DOJ and SEC

February 2020

Client(s) Publicly traded life sciences company

Jones Day represented a publicly traded life sciences company in an internal investigation and resulting self-disclosure to the U.S. Department of Justice ("DOJ") and U.S. Securities and Exchange Commission ("SEC") involving alleged Foreign Corrupt Practices Act ("FCPA") violations arising out of the company's China operations. Jones Day assisted the company in negotiating a civil, administrative settlement with the SEC and obtaining a declination from the DOJ.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.